PFM Health Sciences’s CrowdStrike CRWD Stock Holding History

PFM Health Sciences’s Portfolio CRWD Stock Details CRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-233,536	Closed	-$3.99M	–	77
2019 Q2	$3.99M	Buy	+233,536	New	+$3.97M	0.08%	80

Other funds holding CRWD

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PFM Health Sciences's CRWD Position: Q3 2019 in Review

PFM Health Sciences sold out of CrowdStrike (CRWD) in Q3 2019, closing a stake of 233,536 shares — an estimated $3.99M sold.

PFM Health Sciences first reported a position in CRWD in Q2 2019 and held it in 1 quarter. The position peaked at $3.99M in Q2 2019. 161 funds tracked by Wall St. Rank hold CRWD as of Q3 2019.

PFM Health Sciences reported no remaining CrowdStrike position as of Q3 2019 after selling out during the quarter.
PFM Health Sciences sold 233,536 CrowdStrike shares in Q3 2019, an estimated $3.99M.
PFM Health Sciences first reported a position in CrowdStrike in Q2 2019 and held it in 1 quarter.
PFM Health Sciences's CrowdStrike position peaked at $3.99M in Q2 2019.
161 funds tracked by Wall St. Rank held CrowdStrike as of Q3 2019.

Based on PFM Health Sciences's 13F filing for Q3 2019, filed 14 Nov 2019.